Anke Höllig1, Daniel Remmel2, Birgit Stoffel-Wagner3, Gerrit A Schubert4, Mark Coburn5, Hans Clusmann4. 1. Department of Neurosurgery, RWTH Aachen University, Aachen, Germany; Department of Anesthesiology, RWTH Aachen University, Aachen, Germany. Electronic address: ahoellig@ukaachen.de. 2. Department of Neurosurgery, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany. 3. Institute of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany. 4. Department of Neurosurgery, RWTH Aachen University, Aachen, Germany. 5. Department of Anesthesiology, RWTH Aachen University, Aachen, Germany.
Abstract
OBJECTIVE: Early brain injury after aneurysmal subarachnoid hemorrhage (aSAH) comprises a pronounced neuroinflammatory reaction. Nevertheless, its relevance for functional outcome and its role as outcome predictor remains uncertain. We evaluated the relationship of various early inflammatory parameters regarding functional outcome according to the modified Rankin Scale score (mRS) at discharge (primary objective) and six months after aSAH. PATIENTS: A total of 81 patients (63% female) with a mean age of 53.8 ± 13.2 years were included. METHODS: At admission clinical data and various inflammatory parameters in serum and - wherever applicable - cerebrospinal fluid (CSF) of patients after aSAH were assessed. Outcome was evaluated according to dichotomized mRS at discharge and six months after aSAH (unfavorable outcome: mRS 3-6). Univariate and thereafter multivariate logistic regression analyses were performed using SAS 9.2. RESULTS: Elevated levels of interleukin 6 (IL-6) and leukemia inhibitory factor (LIF) in serum and CSF were related to unfavorable outcome at discharge (p<0.05; univariate analyses). IL-6 remains the only parameter relevant for outcome applying a multivariate model including the relevant baseline characteristics. Six months after aSAH no significant correlation was found regarding the outcome, most likely due to the high drop-out rate (27%). A pronounced rise of LIF serum and CSF levels after aSAH was observed. CONCLUSION: Higher early IL-6 serum levels after aSAH are associated with poor outcome at discharge. In addition, involvement of LIF in the early inflammatory reaction after aSAH has been demonstrated.
OBJECTIVE: Early brain injury after aneurysmal subarachnoid hemorrhage (aSAH) comprises a pronounced neuroinflammatory reaction. Nevertheless, its relevance for functional outcome and its role as outcome predictor remains uncertain. We evaluated the relationship of various early inflammatory parameters regarding functional outcome according to the modified Rankin Scale score (mRS) at discharge (primary objective) and six months after aSAH. PATIENTS: A total of 81 patients (63% female) with a mean age of 53.8 ± 13.2 years were included. METHODS: At admission clinical data and various inflammatory parameters in serum and - wherever applicable - cerebrospinal fluid (CSF) of patients after aSAH were assessed. Outcome was evaluated according to dichotomized mRS at discharge and six months after aSAH (unfavorable outcome: mRS 3-6). Univariate and thereafter multivariate logistic regression analyses were performed using SAS 9.2. RESULTS: Elevated levels of interleukin 6 (IL-6) and leukemia inhibitory factor (LIF) in serum and CSF were related to unfavorable outcome at discharge (p<0.05; univariate analyses). IL-6 remains the only parameter relevant for outcome applying a multivariate model including the relevant baseline characteristics. Six months after aSAH no significant correlation was found regarding the outcome, most likely due to the high drop-out rate (27%). A pronounced rise of LIF serum and CSF levels after aSAH was observed. CONCLUSION: Higher early IL-6 serum levels after aSAH are associated with poor outcome at discharge. In addition, involvement of LIF in the early inflammatory reaction after aSAH has been demonstrated.
Authors: Heikki Kiiski; Jaakko Långsjö; Jyrki Tenhunen; Marika Ala-Peijari; Heini Huhtala; Mari Hämäläinen; Eeva Moilanen; Juha Öhman; Jukka Peltola Journal: eNeurologicalSci Date: 2016-12-02
Authors: Anke Höllig; Birgit Stoffel-Wagner; Hans Clusmann; Michael Veldeman; Gerrit A Schubert; Mark Coburn Journal: Front Neurol Date: 2017-12-22 Impact factor: 4.003
Authors: Eric Peter Thelin; Tamara Tajsic; Frederick Adam Zeiler; David K Menon; Peter J A Hutchinson; Keri L H Carpenter; Maria Cristina Morganti-Kossmann; Adel Helmy Journal: Front Neurol Date: 2017-07-20 Impact factor: 4.003
Authors: Frederick A Zeiler; Eric Peter Thelin; Marek Czosnyka; Peter J Hutchinson; David K Menon; Adel Helmy Journal: Front Neurol Date: 2017-08-08 Impact factor: 4.003
Authors: Heikki Kiiski; Ville Jalkanen; Marika Ala-Peijari; Mari Hämäläinen; Eeva Moilanen; Jukka Peltola; Jyrki Tenhunen Journal: Front Neurol Date: 2017-04-18 Impact factor: 4.003
Authors: Annika Bach; Catharina Conzen; Gerrit Alexander Schubert; Christian Bleilevens; Ute Lindauer Journal: PLoS One Date: 2019-07-30 Impact factor: 3.240